BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 29, 2010
View Archived Issues
For Now, MS Twin Study Yields More Questions, Not Answers
Read More
Lycera's Progress Triggers $11M in Second Part of Series A Round
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Huntington's Drug Snagged on Statistics; Another Trial Needed?
Shares of NeuroSearch A/S sank 30 percent when it turned out the firm's positive Phase III Huntington's disease trial was not quite so positive after all. (BioWorld Today)
Read More
More Bush-Era Stem Cell Lines OK'd by NIH for Federal Funds
Read More